Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia CorpfiledCriticalPharmacia Corp
Priority to SG200808207-5ApriorityCriticalpatent/SG153727A1/en
Publication of SG153727A1publicationCriticalpatent/SG153727A1/en
Disclosed are compounds of Formula (1) and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and R5 are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase and/or TNF activity. Pharmaceutical compositions containing the compounds, methods of preparing the compounds and methods of treatment using the compounds are also disclosed.
SG200808207-5A2003-02-142003-02-14Substituted pyridinones as modulators of p38 map kinase
SG153727A1
(en)